<DOC>
	<DOCNO>NCT00262717</DOCNO>
	<brief_summary>To compare two commercially available platform assessment HIV drug resistance determine provide superior virological result . We hypothesise one test significantly superior .</brief_summary>
	<brief_title>Can Resistance Enhance Selection Treatment ? ( CREST )</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<criteria>HIV infect patient take combination antiretroviral therapy , plasma HIV RNA &gt; 2000copies/mL , willing change ARVs provide informed consent . Patients ARV na√Øve , experience acute illness judge unable comply protocol requirement .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2006</verification_date>
	<keyword>HIV drug resistance test</keyword>
	<keyword>Treatment Experienced</keyword>
</DOC>